Equities
Health CareHealth Care Equipment & Services
  • Price (EUR)29.46
  • Today's Change-0.42 / -1.41%
  • Shares traded4.53k
  • 1 Year change63.30%
  • Beta0.2538
Data delayed at least 30 minutes, as of Jan 23 2017 10:21 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Bastide le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for elderly, sick or handicapped people, for healthcare professionals and individual clients. The Company’s product and services are divided into three divisions: home care equipment and services like wheelchairs, ergonomic pillows, anti-bedsore supports, self-diagnostic equipment and personal assistance products; perfusion and nutrition equipment and services like perfusion instruments, insulin pumps and syringe-drivers and respiratory assistance equipment and services like respirators, oxygen concentrators and oxygen tanks. In addition, the Company is involved in the rental and maintenance of medical equipment, such as insulin pumps, ventilators and nutrition check instruments. It operates through Societe S'Care Assistance, Bordo2 Medica, Medsoft, ATS Rhone Alpes SARL and Air+ Sante.

  • Revenue in EUR (TTM)191.85m
  • Net income in EUR7.18m
  • Incorporated1976
  • Employees1.52k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BLC:PAR since
announced
Transaction
value
Medsoft SASDeal completed03 Jan 201703 Jan 2017Deal completed22.24%--
Bordo2 Medical SADeal completed03 Jan 201703 Jan 2017Deal completed22.24%--
Air + Sante SASDeal completed03 Jan 201703 Jan 2017Deal completed22.24%--
ATS Rhone Alpes SARLDeal completed03 Jan 201703 Jan 2017Deal completed22.24%--
Undisclosed Medical Devices SupplierAnnounced07 Mar 201607 Mar 2016Announced74.11%--
Data delayed at least 30 minutes, as of Jan 23 2017 10:21 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Crossject SA0.00-4.96m45.49m31.00--5.51-----0.7315-0.73150.001.120.004.75-----37.48-29.71-51.41-50.79---802.49---1,118.681.44-1,284.990.00-------31.15------
Stentys SAS7.14m-8.15m46.65m27.00--2.12--6.53-0.5799-0.57990.5041.230.26821.043.44264,444.40-30.60-36.62-38.58-42.3359.3047.09-114.09-343.704.17-147.090.0435--58.4582.0046.96---36.54--
Medicrea International SA28.79m-3.19m51.07m154.00--3.6490.611.77-0.3565-0.35653.251.400.83880.81025.25205,671.30-9.29-4.78-13.87-6.6479.3477.99-11.07-5.050.6882-9.080.4902--14.688.85-48.14--20.39--
Mauna Kea Technologies SAS10.18m-10.07m58.05m83.00--5.43--5.70-0.6344-0.63440.64120.55770.48321.143.29111,912.10-47.77-30.52-64.27-35.7473.5072.61-98.87-119.542.00--0.225---18.7311.749.52---18.02--
Vexim SA16.34m-3.27m75.50m37.00--3.55--4.62-0.4486-0.44862.332.790.85833.634.32441,675.70-17.19-55.91-21.98-72.9329.54-10.34-20.03-85.293.45-328.800.013--34.4466.1228.70------
Pixium Vision SA2.92m-14.60m81.98m37.00--2.83--28.03-1.15-1.150.22932.270.0748--0.734279,043.78-37.36---40.46-------499.32------0.00--35.84---34.73------
EOS Imaging SA25.76m-6.97m91.70m121.00--3.58--3.56-0.3571-0.35711.311.270.53054.001.24212,876.00-14.35-19.48-18.44-26.1347.4842.00-27.04-43.463.41-5.440.4066--8.7225.59-36.91--34.21--
Carmat SA0.00-19.52m176.03m45.00--6.30-----3.78-3.780.004.710.00----0.00-62.53-75.08-72.76-101.54-----------22.230.0985------3.93---24.84--
Amplitude Surgical SA80.79m219.00k203.21m297.00927.191.7218.222.520.00470.00471.722.510.32041.024.31272,013.50-0.0694-2.78-0.0843-3.5746.9245.34-0.2166-8.001.530.58370.4056--13.64--101.24------
Bastide Le Confort Medical SA191.85m7.18m219.34m1.52k30.433.727.641.140.98190.981926.228.031.105.036.03126,051.304.154.137.667.0545.5344.003.763.530.69786.760.56829.9112.0811.945.6517.5711.0611.63
Data as of Jan 23 2017. Currency figures normalised to Bastide le Confort Medical SA's reporting currency: Euro EUR

Institutional shareholders

8.38%Per cent of shares held by top holders
HolderShares% Held
Amundi Asset Management SA (Investment Management)as of 30 Nov 2016155.89k2.12%
Lazard Fr�res Gestion SASas of 30 Jun 2016103.60k1.41%
Portzamparc Gestion SAas of 31 Oct 201676.00k1.04%
Tocqueville Finance SAas of 31 Oct 201666.64k0.91%
Raymond James Asset Management International SAas of 31 Dec 201553.53k0.73%
HSBC Global Asset Management (France) SAas of 30 Sep 201638.36k0.52%
CI Global Investments, Inc.as of 31 Dec 201535.00k0.48%
UBS Asset Management France SAas of 30 Dec 201630.53k0.42%
Martin Maurel Gestion SAas of 30 Dec 201628.41k0.39%
Valeco Finance SAas of 30 Sep 201626.93k0.37%
More ▼
Data from 31 Dec 2015 - 30 Dec 2016Source: FactSet Research Systems Inc.
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.